{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:32:15Z","timestamp":1772580735349,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Screening of Cushing Syndrome (CS) and Mild Autonomous Cortisol Secretion (MACS) in hypertensive patients is crucial for proper treatment. The aim of the study was to investigate screening and management of hypercortisolism among patients with hypertension in Italy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A 10 item-questionnaire was delivered to referral centres of European and Italian Society of Hypertension (ESH and SIIA) in a nationwide survey. Data were analyzed according to type of centre (excellence <jats:italic>vs<\/jats:italic> non-excellence), geographical area, and medical specialty.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Within 14 Italian regions, 82 centres (30% excellence, 78.790 patients during the last year, average 600 patients\/year) participated to the survey. Internal medicine (44%) and cardiology (31%) were the most prevalent medical specialty. CS and MACS were diagnosed in 313 and 490 patients during the previous 5\u00a0years. The highest number of diagnoses was reported by internal medicine and excellence centres. Screening for hypercortisolism was reported by 77% in the presence of specific features of CS, 61% in resistant hypertension, and 38% in patients with adrenal mass. Among screening tests, the 24\u00a0h urinary free cortisol was the most used (66%), followed by morning cortisol and ACTH (54%), 1\u00a0mg-dexamethasone suppression test (49%), adrenal CT or MRI scans (12%), and late night salivary cortisol (11%). Awareness of referral centres with expertise in management of CS was reported by 67% of the participants, which reduced to 44% among non-excellence centres.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Current screening of hypercortisolism among hypertensive patients is unsatisfactory. Strategies tailored to different medical specialties and type of centres should be conceived.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-024-02387-2","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T14:02:14Z","timestamp":1719237734000},"page":"3029-3038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Screening of hypercortisolism among patients with hypertension: an Italian nationwide survey"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1291-8906","authenticated-orcid":false,"given":"G.","family":"Di Dalmazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Goi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Burrello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F. G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mancusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Coletti Moia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Muiesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mulatero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"issue":"12","key":"2387_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol dicembre 9(12):847\u2013875","journal-title":"Lancet Diabetes Endocrinol dicembre"},{"issue":"1","key":"2387_CR2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A (2023) European Society of endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 189(1):G1-42","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2387_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","volume":"41","author":"M Sherlock","year":"2020","unstructured":"Sherlock M, Scarsbrook A, Abbas A, Fraser S, Limumpornpetch P, Dineen R et al (2020) Adrenal incidentaloma. Endocr Rev 41(6):775\u2013820","journal-title":"Endocr Rev"},{"issue":"7","key":"2387_CR4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1210\/clinem\/dgad044","volume":"108","author":"E Sconfienza","year":"2023","unstructured":"Sconfienza E, Tetti M, Forestiero V, Veglio F, Mulatero P, Monticone S (2023) Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab 108(7):1813","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2387_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BMK, Colao A (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol luglio 4(7):611\u2013629","journal-title":"Lancet Diabetes Endocrinol luglio"},{"issue":"6","key":"2387_CR6","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u00f3 E, J\u00f8rgensen JOL, Cannegieter SC, Ehrenstein V, Vandenbroucke JP et al (2013) Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study. J Clin Endocrinol Metab giugno 98(6):2277\u20132284","journal-title":"J Clin Endocrinol Metab giugno"},{"issue":"11","key":"2387_CR7","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1210\/jc.2019-00365","volume":"104","author":"G Di Dalmazi","year":"2019","unstructured":"Di Dalmazi G, Fanelli F, Zavatta G, Ricci Bitti S, Mezzullo M, Repaci A et al (2019) The steroid profile of adrenal incidentalomas: subtyping subjects with high cardiovascular risk. J Clin Endocrinol Metab 104(11):5519\u20135528","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2387_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","volume":"2","author":"G Di Dalmazi","year":"2014","unstructured":"Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E et al (2014) Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol maggio 2(5):396\u2013405","journal-title":"Lancet Diabetes Endocrinol maggio"},{"issue":"1","key":"2387_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1530\/EJE-17-0047","volume":"177","author":"V Morelli","year":"2017","unstructured":"Morelli V, Palmieri S, Lania A, Tresoldi A, Corbetta S, Cairoli E et al (2017) Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks. Eur J Endocrinol luglio 177(1):73\u201383","journal-title":"Eur J Endocrinol luglio"},{"key":"2387_CR10","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa270","author":"G Di Dalmazi","year":"2020","unstructured":"Di Dalmazi G, Vicennati V, Pizzi C, Mosconi C, Tucci L, Balacchi C et al (2020) Prevalence and incidence of atrial fibrillation in a large cohort of adrenal incidentalomas: A long-term study. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa270","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2387_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","volume":"10","author":"T Deutschbein","year":"2022","unstructured":"Deutschbein T, Reimondo G, Dalmazi GD, Bancos I, Patrova J, Vassiliadi DA et al (2022) Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol 10(7):499\u2013508","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2387_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27(3):193\u2013202. https:\/\/doi.org\/10.1291\/hypres.27.193","journal-title":"Hypertens Res"},{"issue":"5","key":"2387_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/HJH.0b013e3283521484","volume":"30","author":"LC Martins","year":"2012","unstructured":"Martins LC, Concei\u00e7\u00e3o FL, Muxfeldt ES, Salles GF (2012) Prevalence and associated factors of subclinical hypercortisolism in patients with resistant hypertension. J Hypertens 30(5):967\u2013973. https:\/\/doi.org\/10.1097\/HJH.0b013e3283521484","journal-title":"J Hypertens"},{"issue":"8","key":"2387_CR14","first-page":"2664","volume":"84","author":"A Colao","year":"1999","unstructured":"Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M et al (1999) Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure. J Clin Endocrinol Metab 84(8):2664\u20132672","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2387_CR15","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BMK, Findling JW, Murad MH, Newell-Price J, Savage MO et al (2015) Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807\u20132831","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2387_CR16","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1097\/HJH.0000000000003252","volume":"40","author":"F Fallo","year":"2022","unstructured":"Fallo F, Di Dalmazi G, Beuschlein F, Biermasz NR, Castinetti F, Elenkova A et al (2022) Diagnosis and management of hypertension in patients with Cushing\u2019s syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens novembre 40(11):2085","journal-title":"J Hypertens novembre"},{"issue":"6","key":"2387_CR17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.surg.2012.08.054","volume":"152","author":"M Iacobone","year":"2012","unstructured":"Iacobone M, Citton M, Viel G, Boetto R, Bonadio I, Mondi I et al (2012) Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing\u2019s syndrome. Surgery 152(6):991\u2013997","journal-title":"Surgery"},{"key":"2387_CR18","doi-asserted-by":"publisher","first-page":"898084","DOI":"10.3389\/fendo.2022.898084","volume":"13","author":"V Morelli","year":"2022","unstructured":"Morelli V, Frigerio S, Aresta C, Passeri E, Pugliese F, Copetti M et al (2022) Adrenalectomy improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion: results of a RCT. Front Endocrinol 13:898084","journal-title":"Front Endocrinol"},{"key":"2387_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz136","author":"G Rubinstein","year":"2020","unstructured":"Rubinstein G, Osswald A, Hoster E, Losa M, Elenkova A, Zacharieva S et al (2020) Time to diagnosis in Cushing\u2019s syndrome: a meta-analysis based on 5367 patients. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz136","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2387_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jama.2023.11305","volume":"330","author":"M Reincke","year":"2023","unstructured":"Reincke M, Fleseriu M (2023) Cushing syndrome: a review. JAMA 330(2):170\u2013181","journal-title":"JAMA"},{"issue":"2","key":"2387_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.118.12191","volume":"73","author":"RM Carey","year":"2019","unstructured":"Carey RM, Sakhuja S, Calhoun DA, Whelton PK, Muntner P (2019) Prevalence of apparent treatment-resistant hypertension in the United States. Hypertension febbraio 73(2):424\u2013431","journal-title":"Hypertension febbraio"},{"issue":"8","key":"2387_CR22","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/s41440-021-00845-5","volume":"45","author":"M Yoon","year":"2022","unstructured":"Yoon M, You SC, Oh J, Lee CJ, Lee SH, Kang SM et al (2022) Prevalence and prognosis of refractory hypertension diagnosed using ambulatory blood pressure measurements. Hypertens Res agosto 45(8):1353\u20131362","journal-title":"Hypertens Res agosto"},{"issue":"5","key":"2387_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","volume":"12","author":"GH Anderson","year":"1994","unstructured":"Anderson GH, Blakeman N, Streeten DH (1994) The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens maggio 12(5):609\u2013615","journal-title":"J Hypertens maggio"},{"issue":"3","key":"2387_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res Off J Jpn Soc Hypertens. 27(3):193\u2013202","journal-title":"Hypertens Res Off J Jpn Soc Hypertens."},{"issue":"5","key":"2387_CR25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/HJH.0b013e3283521484","volume":"30","author":"LC Martins","year":"2012","unstructured":"Martins LC, Concei\u00e7\u00e3o FL, Muxfeldt ES, Salles GF (2012) Prevalence and associated factors of subclinical hypercortisolism in patients with resistant hypertension. J Hypertens maggio 30(5):967\u2013973","journal-title":"J Hypertens maggio"},{"issue":"9","key":"2387_CR26","doi-asserted-by":"publisher","first-page":"e3723","DOI":"10.1210\/clinem\/dgac379","volume":"107","author":"LT Braun","year":"2022","unstructured":"Braun LT, Vogel F, Zopp S, Marchant Seiter T, Rubinstein G, Berr CM et al (2022) Whom should we screen for Cushing syndrome? The endocrine society practice guideline recommendations 2008 revisited. J Clin Endocrinol Metab 107(9):e3723\u2013e3730","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2387_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1530\/EJE-13-0824","volume":"170","author":"AG Ambrogio","year":"2014","unstructured":"Ambrogio AG, De Martin M, Ascoli P, Cavagnini F, Pecori GF (2014) Gender-dependent changes in haematological parameters in patients with cushing\u2019s disease before and after remission. Eur J Endocrinol 170(3):393\u2013400. https:\/\/doi.org\/10.1530\/EJE-13-0824","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2387_CR28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/EJE-22-0211","volume":"187","author":"M Detomas","year":"2022","unstructured":"Detomas M, Altieri B, Chifu I, Remde H, Zhou X, Landwehr LS, Sbiera S, Kroiss M, Fassnacht M, Deutschbein T (2022) Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism. Eur J Endocrinol 187(3):439\u2013449. https:\/\/doi.org\/10.1530\/EJE-22-0211","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2387_CR29","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","volume":"189","author":"ICM Pelsma","year":"2023","unstructured":"Pelsma ICM, Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A et al (2023) Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. Eur J Endocrinol 189(4):S88-101","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2387_CR30","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1210\/clinem\/dgaa105","volume":"105","author":"BP Galm","year":"2020","unstructured":"Galm BP, Qiao N, Klibanski A, Biller BMK, Tritos NA (2020) Accuracy of laboratory tests for the diagnosis of Cushing syndrome. J Clin Endocrinol Metab 105(6):2081\u20132094","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2387_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11102-022-01249-5","volume":"25","author":"S Petersenn","year":"2022","unstructured":"Petersenn S (2022) Overnight 1 mg dexamethasone suppression test and 24 h urine free corticy and pitfalls when screening for Cushing\u2019s syndrome. Pituitary 25(5):693\u2013697","journal-title":"Pituitary"},{"issue":"8","key":"2387_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13111","volume":"34","author":"M Balomenaki","year":"2022","unstructured":"Balomenaki M, Margaritopoulos D, Vassiliadi DA, Tsagarakis S (2022) Diagnostic workup of Cushing\u2019s syndrome. J Neuroendocrinol 34(8):e13111","journal-title":"J Neuroendocrinol"},{"key":"2387_CR33","doi-asserted-by":"publisher","first-page":"e843","DOI":"10.1016\/j.wneu.2021.11.079","volume":"158","author":"G Watanabe","year":"2022","unstructured":"Watanabe G, Choi SY, Adamson DC (2022) Pituitary incidentalomas in the united states: a national database estimate. World Neurosurg 158:e843\u2013e855","journal-title":"World Neurosurg"},{"issue":"6","key":"2387_CR34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","volume":"61","author":"T Mancini","year":"2004","unstructured":"Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G (2004) High cardiovascular risk in patients with Cushing\u2019s syndrome according to 1999 WHO\/ISH guidelines. Clin Endocrinol (Oxf) 61(6):768\u2013777","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2387_CR35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","volume":"75","author":"R Giordano","year":"2011","unstructured":"Giordano R, Picu A, Marinazzo E, D\u2019Angelo V, Berardelli R, Karamouzis I et al (2011) Metabolic and cardiovascular outcomes in patients with Cushing\u2019s syndrome of different aetiologies during active disease and 1 year after remission. Clin Endocrinol (Oxf) 75(3):354\u2013360","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2387_CR36","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1210\/jc.2010-1942","volume":"96","author":"RN Clayton","year":"2011","unstructured":"Clayton RN, Raskauskiene D, Reulen RC, Jones PW (2011) Mortality and morbidity in Cushing\u2019s disease over 50 years in stoke-on-trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 96(3):632\u2013642","journal-title":"J Clin Endocrinol Metab"},{"key":"2387_CR37","unstructured":"Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas (CHIRACIC). ClinicalTrials.gov ID: NCT02364089. 2015. Sponsor: University Hospital, Bordeaux."},{"key":"2387_CR38","unstructured":"Effect of the treatment with Metyrapone on the cardiovascular risk in patients with adrenal incidentalomas and subclinical Cushing's syndrome. EudraCT: 2019-002008-41. 2019. Sponsor: IRCCS S. Orsola Policlinic, University of Bologna, Bologna"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02387-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02387-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02387-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T06:16:30Z","timestamp":1731046590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02387-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02387-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,24]]},"assertion":[{"value":"21 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studie with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}